These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
290 related articles for article (PubMed ID: 30826152)
1. CHPF promotes lung adenocarcinoma proliferation and anti-apoptosis via the MAPK pathway. Hou XM; Zhang T; Da Z; Wu XA Pathol Res Pract; 2019 May; 215(5):988-994. PubMed ID: 30826152 [TBL] [Abstract][Full Text] [Related]
2. Actin-like protein 8 promotes cell proliferation, colony-formation, proangiogenesis, migration and invasion in lung adenocarcinoma cells. Ma S; Wang X; Zhang Z; Liu D Thorac Cancer; 2020 Mar; 11(3):526-536. PubMed ID: 31962007 [TBL] [Abstract][Full Text] [Related]
3. Overexpression of KIF18A promotes cell proliferation, inhibits apoptosis, and independently predicts unfavorable prognosis in lung adenocarcinoma. Zhong Y; Jiang L; Lin H; Li X; Long X; Zhou Y; Li B; Li Z IUBMB Life; 2019 Jul; 71(7):942-955. PubMed ID: 30817091 [TBL] [Abstract][Full Text] [Related]
4. Knockdown of microsomal glutathione S-transferase 1 inhibits lung adenocarcinoma cell proliferation and induces apoptosis. Zeng B; Ge C; Li R; Zhang Z; Fu Q; Li Z; Lin Z; Liu L; Xue Y; Xu Y; He J; Guo H; Li C; Huang W; Song X; Huang Y Biomed Pharmacother; 2020 Jan; 121():109562. PubMed ID: 31707341 [TBL] [Abstract][Full Text] [Related]
5. The role of EMG1 in lung adenocarcinoma progression: Implications for prognosis and immune cell infiltration. Wu X; Wu Z; Xie Z; Huang H; Wang Y; Lv K; Yang H; Liu X Int Immunopharmacol; 2024 Sep; 138():112553. PubMed ID: 38943975 [TBL] [Abstract][Full Text] [Related]
6. LDH-A promotes malignant behavior via activation of epithelial-to-mesenchymal transition in lung adenocarcinoma. Hou XM; Yuan SQ; Zhao D; Liu XJ; Wu XA Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30509961 [TBL] [Abstract][Full Text] [Related]
7. Expression of CHPF modulates cell proliferation and invasion in lung cancer. Cao C; Liu Y; Wang Q; Zhao J; Shi M; Zheng J Braz J Med Biol Res; 2020; 53(5):e9021. PubMed ID: 32348423 [TBL] [Abstract][Full Text] [Related]
8. Agmatinase promotes the lung adenocarcinoma tumorigenesis by activating the NO-MAPKs-PI3K/Akt pathway. Zhu HE; Yin JY; Chen DX; He S; Chen H Cell Death Dis; 2019 Nov; 10(11):854. PubMed ID: 31699997 [TBL] [Abstract][Full Text] [Related]
9. Plakophilin-2 accelerates cell proliferation and migration through activating EGFR signaling in lung adenocarcinoma. Hao XL; Tian Z; Han F; Chen JP; Gao LY; Liu JY Pathol Res Pract; 2019 Jul; 215(7):152438. PubMed ID: 31126818 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of CENPF is associated with progression and poor prognosis of lung adenocarcinoma. Li MX; Zhang MY; Dong HH; Li AJ; Teng HF; Liu AL; Xu N; Qu YQ Int J Med Sci; 2021; 18(2):494-504. PubMed ID: 33390818 [No Abstract] [Full Text] [Related]
11. MiR-188 inhibits proliferation and promotes apoptosis of lung adenocarcinoma cells by targeting SIX1 to negatively regulate ERK signaling pathway. Lv DQ; Li HY; Wu XM; Lin L; Yan SQ; Guo QY Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):721-727. PubMed ID: 32016974 [TBL] [Abstract][Full Text] [Related]
12. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway. Wei C; Dong X; Lu H; Tong F; Chen L; Zhang R; Dong J; Hu Y; Wu G; Dong X J Exp Clin Cancer Res; 2019 Feb; 38(1):95. PubMed ID: 30791942 [TBL] [Abstract][Full Text] [Related]
13. LncRNA LINC00680 promotes lung adenocarcinoma growth via binding to GATA6 and canceling GATA6-mediated suppression of SOX12 expression. Sun X; Wang R; Tan M; Tian X; Meng J Exp Cell Res; 2021 Aug; 405(1):112653. PubMed ID: 34029572 [TBL] [Abstract][Full Text] [Related]
14. High expression of keratin 6C is associated with poor prognosis and accelerates cancer proliferation and migration by modulating epithelial-mesenchymal transition in lung adenocarcinoma. Hu HB; Yang XP; Zhou PX; Yang XA; Yin B Genes Genomics; 2020 Feb; 42(2):179-188. PubMed ID: 31768767 [TBL] [Abstract][Full Text] [Related]
15. Elevated FAM83A expression predicts poorer clincal outcome in lung adenocarcinoma. Zhang J; Sun G; Mei X Cancer Biomark; 2019; 26(3):367-373. PubMed ID: 31594212 [TBL] [Abstract][Full Text] [Related]
16. PYCR1 knockdown inhibits the proliferation, migration, and invasion by affecting JAK/STAT signaling pathway in lung adenocarcinoma. Gao Y; Luo L; Xie Y; Zhao Y; Yao J; Liu X Mol Carcinog; 2020 May; 59(5):503-511. PubMed ID: 32133692 [TBL] [Abstract][Full Text] [Related]
17. CHPF promotes gastric cancer tumorigenesis through the activation of E2F1. Lin X; Han T; Xia Q; Cui J; Zhuo M; Liang Y; Su W; Wang L; Wang L; Liu Z; Xiao X Cell Death Dis; 2021 Sep; 12(10):876. PubMed ID: 34564711 [TBL] [Abstract][Full Text] [Related]
18. Identification of chondroitin polymerizing factor (CHPF) as tumor promotor in cholangiocarcinoma through regulating cell proliferation, cell apoptosis and cell migration. Duan X; Yang J; Jiang B; Duan W; Wei R; Zhang H; Mao X Cell Cycle; 2021; 20(5-6):591-602. PubMed ID: 33651657 [TBL] [Abstract][Full Text] [Related]
19. GALNT2 promotes cell proliferation, migration, and invasion by activating the Notch/Hes1-PTEN-PI3K/Akt signaling pathway in lung adenocarcinoma. Wang W; Sun R; Zeng L; Chen Y; Zhang N; Cao S; Deng S; Meng X; Yang S Life Sci; 2021 Jul; 276():119439. PubMed ID: 33785338 [TBL] [Abstract][Full Text] [Related]
20. Chondroitin polymerizing factor (CHPF) promotes the progression of colorectal cancer through ASB2-mediated ubiquitylation of SMAD9. Zhao J; Tang X; Zhu H Histol Histopathol; 2024 Nov; 39(11):1493-1503. PubMed ID: 38591191 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]